ANIX
ANIXA BIOSCINCS (ANIX)
NASDAQ
$2.62+$0.10 (+4.13%)
Price as of Jun 03, 2026 7:53 PM EDT
  • $90.5M
    Market Cap
  • -9.68%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
10/31/2025
10/31/2024
10/31/2023
10/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
210,000
0.00%
210,000
-58.98%
512,000
-0.10%
Cost of Revenue
4.9M
-45.93%
9.0M
+39.52%
6.5M
-10.17%
7.2M
+29.16%
Gross Profit
-4.9M
-44.64%
-8.8M
+40.84%
-6.3M
-6.44%
-6.7M
+32.11%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
-6.4M
+34.12%
-4.8M
-28.85%
-6.7M
+8.29%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
11.7M
-15.40%
13.8M
+23.26%
11.2M
-19.13%
13.9M
+1.66%
Operating Profit
-11.7M
-15.40%
-13.8M
+25.61%
-11.0M
-20.64%
-13.9M
+5.63%
Interest Income
673,000
-40.60%
1.1M
+4.81%
1.1M
+939.42%
104,000
+4,378.90%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
673,000
-40.60%
1.1M
+4.81%
1.1M
+939.42%
104,000
+4,378.90%
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-11.7M
-15.40%
-13.8M
+25.61%
-11.0M
-20.64%
-13.9M
+5.63%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-10.9M
-12.96%
-12.6M
+27.96%
-9.8M
-27.83%
-13.6M
+4.95%
Net Income from Continuing Operations Applicable to Common
-10.9M
-12.96%
-12.6M
+27.96%
-9.8M
-27.83%
-13.6M
+4.95%
Basic EPS and Net Income
-0.34
-12.82%
-0.39
-221.87%
0.32
+171.11%
-0.45
0.00%
Diluted EPS and Net Income
-0.34
-12.82%
-0.39
-221.87%
0.32
+171.11%
-0.45
0.00%
Basic Weighted Average Shares
32,454
+1.74%
31,898
+2.96%
30,980
-99.90%
30.4M
+6.28%
Diluted Weighted Average Shares
32,454
+1.74%
31,898
+2.96%
30,980
-99.90%
30.4M
+6.28%
Balance Sheet
Cash and Cash Equivalents
1.2M
-2.12%
1.3M
+38.91%
915,000
-92.60%
12.4M
-57.57%
Short-Term Investments
13.9M
-25.32%
18.7M
-18.65%
22.9M
+32.33%
17.3M
+162.55%
Cash and Cash Equivalents and Short-Term Investments
15.2M
-23.84%
19.9M
-16.44%
23.8M
-19.68%
29.7M
-16.91%
Total Current Assets
15.9M
-25.63%
21.4M
-15.75%
25.4M
-16.04%
30.2M
-16.12%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
16.1M
-25.52%
21.6M
-15.40%
25.5M
-16.08%
30.4M
-16.12%
Income Taxes Payable
N/A
N/A
N/A
N/A
1.8M
+2.55%
1.7M
+57.63%
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.0M
-21.32%
2.5M
+23.27%
2.0M
-0.44%
2.0M
+60.33%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
163,000
-19.70%
203,000
+65.04%
123,000
-29.71%
175,000
-20.48%
Total Liabilities
2.1M
-21.20%
2.7M
+25.66%
2.2M
-2.76%
2.2M
+48.40%
Retained Earnings
-251.7M
+4.54%
-240.8M
+5.50%
-228.2M
+4.49%
-218.4M
+6.64%
Total Stockholders Equity
15.2M
-24.19%
20.0M
-17.83%
24.3M
-16.22%
29.0M
-18.03%
Total Shares Outstanding
33.0M
+2.54%
32.2M
+3.38%
31.1M
+0.75%
30.9M
+2.87%
Cash Flow
Cash from Operating Activities
-7.2M
-2.21%
-7.3M
+18.13%
-6.2M
-4.36%
-6.5M
+31.50%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
4.9M
+13.80%
4.3M
+176.33%
-5.6M
-47.78%
-10.7M
+173.84%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
2.3M
-33.24%
3.4M
+833.06%
366,000
-19.03%
452,000
-98.57%
Financials Ratio
Gross Margin
N/A
N/A
-4,209.05%
+40.84%
-2,988.57%
N/A
N/A
N/A
Operating Margin
N/A
N/A
-6,586.19%
+25.61%
-5,243.33%
N/A
N/A
N/A
Return on Assets
-58.01%
+8.86%
-53.29%
+51.92%
-35.08%
N/A
N/A
N/A
Return on Equity
-62.16%
+9.76%
-56.63%
+54.08%
-36.76%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
0.00%
+100.00%
-58.98%
N/A
N/A
N/A
Current Ratio
8.08
-5.48%
8.54
-31.66%
12.50
N/A
N/A
N/A
Cash Ratio
0.63
+24.39%
0.51
+12.68%
0.45
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow